IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Achillion Pharmaceuticals in

CUSIP: 00448Q901 | 10 institutional holders

Quarters

Q1 2020Q4 2019Q3 2019Q2 2019Q1 2019
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile